Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • 0,0 (0)
  • CIÊNCIAS DA VIDA
  • DIARIAMENTE

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

  1. Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals

    -21 H

    Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals

    Pharmaceutical Executive

    3 min
  2. Moving CAR-T Beyond Oncology

    -1 DIA

    Moving CAR-T Beyond Oncology

    Vincent Hennemand discusses using these types of therapies to develop treatments for autoimmune conditions.

    8 min
  3. Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development

    -1 DIA

    Pharmaceutical Executive Daily: FDA's New Guidance for Biosimilar Development

    In today's Pharmaceutical Executive Daily, the FDA issues new draft guidance aimed at reducing the cost and complexity of biosimilar development, Novo Nordisk responds to an FDA warning letter stemming from a 2025 inspection of its U.S. headquarters, and Pharmaceutical Executive's latest analysis examines the state of the biopharma industry as it navigates a period of cautious momentum.

    2 min
  4. Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin

    -2 DIAS

    Pharmaceutical Executive Daily: FDA Expands Approval of Leucovorin

    In today's Pharmaceutical Executive Daily, the FDA approves leucovorin as the first-ever treatment for an ultra-rare genetic condition called cerebral folate transport deficiency, Enhertu receives FDA Priority Review for HER2-positive early breast cancer in the post-neoadjuvant setting, and a new commentary argues that AI has fundamentally changed how healthcare communicators must think about content strategy.

    2 min
  5. Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time

    -4 DIAS

    Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time

    In today’s Pharmaceutical Executive Daily, Vinay Prasad exits the FDA’s Center for Biologics Evaluation and Research for the second time in under a year, major deal activity including a GSK and Alfasigma licensing agreement along with Servier’s $2 billion acquisition of Day One Pharmaceuticals, and Ipsen withdraws Tazverik from the market following emerging clinical trial data.

    2 min
  6. Pharmaceutical Executive Daily: Cognito Therapeutics and Nexcure Secure Financing Rounds

    5/03

    Pharmaceutical Executive Daily: Cognito Therapeutics and Nexcure Secure Financing Rounds

    In today’s Pharmaceutical Executive Daily, Cognito Therapeutics and Nexcure secure new financing rounds to advance their pipelines, artificial intelligence and large language models reshape pharmacovigilance and drug safety monitoring, and Eli Lilly launches a new Employer Connect platform to expand obesity treatment coverage options.

    2 min
  7. Pharmaceutical Executive Daily: Pharma Industry's AI Adoption

    4/03

    Pharmaceutical Executive Daily: Pharma Industry's AI Adoption

    In today’s Pharmaceutical Executive Daily, Antengene and UCB enter a billion-dollar global licensing agreement for a bispecific T-cell engager, Teva signs a $400 million strategic growth capital agreement with Blackstone Life Sciences, and industry leaders explore the technological renaissance driven by AI integration.

    2 min
  8. The Ongoing Impact of MFN Pricing

    4/03

    The Ongoing Impact of MFN Pricing

    Alice Valdur Curan discusses how the industry continues to strategize around this complicated order.

    17 min
Ver tudo (308)

Sobre

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

Informação

  • Autoria
    Pharmaceutical Executive Podcast
  • Anos em atividade
    2018 - 2026
  • Episódios
    308
  • Classificação
    Para todos
  • Site do programa
    Pharmaceutical Executive

Talvez também goste